Related Experiment Videos
Cryptococcus neoformans antibody levels in patients with AIDS
F Dromer1, P Aucouturier, J P Clauvel
1Laboratoire des Infections Expérimentales, Faculté Xavier Bichat, Paris, France.
Scandinavian Journal of Infectious Diseases
|January 1, 1988
Summary
Patients with AIDS show a reduced ability to produce IgG antibodies against Cryptococcus neoformans capsular polysaccharide (CPS). This deficiency may compromise their immune defense against cryptococcosis, highlighting a critical aspect of AIDS-related immune dysfunction.
Area of Science:
- Immunology
- Infectious Diseases
- Virology
Background:
- Cryptococcus neoformans is an opportunistic fungal pathogen.
- AIDS patients exhibit compromised immune systems, increasing susceptibility to infections.
- Cryptococcosis is a significant opportunistic infection in individuals with advanced HIV/AIDS.
Purpose of the Study:
- To investigate the levels of anti-Cryptococcus neoformans capsular polysaccharide (CPS) antibodies in patients with AIDS.
- To compare antibody responses between AIDS patients and healthy controls.
- To assess the potential impact of antibody deficiencies on cryptococcosis susceptibility in AIDS.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure total, IgG, and IgM anti-CPS antibody activity.
- Study included patients with AIDS-related complex or AIDS and heterosexual healthy controls.
Main Results:
- Total and IgG anti-CPS antibody activity was rarely detected in AIDS patients.
- Mean levels of total and IgG anti-CPS antibodies were significantly lower in AIDS patients compared to controls.
- IgM anti-CPS antibody activity was similar across AIDS patients and healthy controls.
Conclusions:
- AIDS patients demonstrate an impaired ability to synthesize specific IgG antibodies against Cryptococcus neoformans CPS.
- This deficiency in IgG antibody production may hinder an alternative host defense mechanism, potentially increasing the risk and severity of cryptococcosis in AIDS.
- The findings underscore the importance of humoral immunity in controlling fungal infections like cryptococcosis, especially in immunocompromised individuals.